Does XOMA Royalty (XOMA) Have the Potential to Rally 85.34% as Wall Street Analysts Expect? — Positive

XOMA   Zacks Investment Research — September 19, 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 85.3% in XOMA Royalty (XOMA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Does XOMA Royalty (XOMA) Have the Potential to Rally 85.34% as Wall Street Analysts Expect?

Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross? — Positive

STTK   Zacks Investment Research — September 19, 2025

Shattuck Labs, Inc. (STTK) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, STTK's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

image for news Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?

Wall Street Analysts Think Fiverr (FVRR) Could Surge 26.93%: Read This Before Placing a Bet — Positive

FVRR   Zacks Investment Research — September 19, 2025

The mean of analysts' price targets for Fiverr (FVRR) points to a 26.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Think Fiverr (FVRR) Could Surge 26.93%: Read This Before Placing a Bet

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sable (SOC) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Sable between May 19, 2025 and June 3, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

image for news SABLE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sable Offshore Corporation and Encourages Investors to Contact the Firm

I rate ProKidney a buy due to promising Phase 2 data for rilparencel in advanced CKD, strong FDA alignment, and sufficient cash runway. PROK's Phase 3 PROACT 1 study uses eGFR slope as a surrogate endpoint, with topline data expected in Q2 2027 and potential for accelerated approval. The company halted its second Phase 3 trial, saving over $150m, and expects positive REGEN-007 results to be presented at ASN Kidney Week in November.

image for news ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy

Will Medifast's Strategic Endeavors Deliver Growth in 2025? — Positive

MED   Zacks Investment Research — September 19, 2025

MED boosts growth efforts with new products, digital tools and an expanded OPTAVIA coaching network.

image for news Will Medifast's Strategic Endeavors Deliver Growth in 2025?

Bet on Low-Beta Stocks STNG, BZ & TME as Market Uncertainty Remains — Neutral

BZ  STNG  TME   Zacks Investment Research — September 19, 2025

Scorpio Tankers, Kanzhun and Tencent Music emerge as low-beta picks to help investors navigate ongoing market volatility.

image for news Bet on Low-Beta Stocks STNG, BZ & TME as Market Uncertainty Remains

ExxonMobil's Permian Push: Leveraging Technology for Production Growth — Positive

XOM   Zacks Investment Research — September 19, 2025

XOM boosts Permian potential with new tech, lifting recoverable resources and targeting 2.3M boe output by 2030.

image for news ExxonMobil's Permian Push: Leveraging Technology for Production Growth

PTC Unveils Arena AI Assistant & Supply Chain Intelligence Enhancements — Positive

PTC   Zacks Investment Research — September 19, 2025

PTC expands its Arena portfolio with an AI-powered assistant, new supply chain tools and CAD-PLM integration to boost collaboration and efficiency.

image for news PTC Unveils Arena AI Assistant & Supply Chain Intelligence Enhancements

Here's Why Curtiss-Wright (CW) is a Strong Momentum Stock — Positive

CW   Zacks Investment Research — September 19, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Here's Why Curtiss-Wright (CW) is a Strong Momentum Stock

Here's Why Dropbox (DBX) is a Strong Momentum Stock — Positive

DBX   Zacks Investment Research — September 19, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Here's Why Dropbox (DBX) is a Strong Momentum Stock

Here's Why Aptiv PLC (APTV) is a Strong Momentum Stock — Positive

APTV   Zacks Investment Research — September 19, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Here's Why Aptiv PLC (APTV) is a Strong Momentum Stock

Why Qorvo (QRVO) is a Top Momentum Stock for the Long-Term — Positive

QRVO   Zacks Investment Research — September 19, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Why Qorvo (QRVO) is a Top Momentum Stock for the Long-Term

Here's Why Ralph Lauren (RL) is a Strong Momentum Stock — Positive

RL   Zacks Investment Research — September 19, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why Ralph Lauren (RL) is a Strong Momentum Stock

Why TransMedics (TMDX) is a Top Momentum Stock for the Long-Term — Positive

TMDX   Zacks Investment Research — September 19, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Why TransMedics (TMDX) is a Top Momentum Stock for the Long-Term

Here's Why Vornado (VNO) is a Strong Momentum Stock — Positive

VNO   Zacks Investment Research — September 19, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Here's Why Vornado (VNO) is a Strong Momentum Stock

Here's Why Paypal (PYPL) is a Strong Momentum Stock — Positive

PYPL   Zacks Investment Research — September 19, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Here's Why Paypal (PYPL) is a Strong Momentum Stock

FedEx Stock Higher as Earnings Beat Triggers Bull Notes — Positive

FDX   Schaeffers Research — September 19, 2025

FedEx Corp (NYSE:FDX) stock is up 2.3% to trade at $232.06 at last glance, after the transportation company announced better-than-expected earnings and revenue for the fiscal first quarter and hiked its full-year outlook.

image for news FedEx Stock Higher as Earnings Beat Triggers Bull Notes

Lennar Corporation enjoys stable housing demand with its strategic pricing without sacrificing its profits. Its robust balance sheet ensures the sustainability of its large operating capacity and dividend payouts. Its valuation shows a limited upside, but it has already priced in market risks, making it reasonable at this level.

image for news Lennar: Strategic Pricing And Robust Liquidity Amid Rate Cuts Provide Some Insulation

Is the Options Market Predicting a Spike in Adherex Technologies Stock? — Neutral

FENC   Zacks Investment Research — September 19, 2025

Investors need to pay close attention to Adherex Technologies stock based on the movements in the options market lately.

image for news Is the Options Market Predicting a Spike in Adherex Technologies Stock?